Andere Sprachen Concord Drugs Limited

Aktien

CONCORD6

INE858L01010

CONCORD6

Verzögert Bombay S.E. Andere Börsenplätze 08:55:30 01.07.2024			% 5 Tage	% 1. Jan.
38,9 ^INR	+0,03 %		+0,05 %	-34,86 %

30.05.	Concord Drugs Limited meldet Ergebnis für das vierte Quartal und das Gesamtjahr bis zum 31. März 2024	CI
19.03.	Concord Drugs Limited gibt die Ernennung von Namratha Nagla als Company Secretary/Compliance Officer bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Concord Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	30.05.
Concord Drugs Limited Announces Appointment of Namratha Nagla as Company Secretary/Compliance Officer	19.03.
Concord Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13.02.
Concord Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14.11.
Concord Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14.08.23
Concord Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14.08.23
Concord Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30.05.23
Concord Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30.05.23
Concord Drugs Eyes INR 207 Million Rights Issue	14.04.23
Concord Drugs Limited Announces Resignation of AnkurBisht, Company Secretary and Compliance Officer	08.04.23
Concord Drugs Limited acquired 100% stake in Proton Remedies Private Limited for INR 14.2 million.	23.03.23
Concord Drugs Limited Appoints Mr. Ankur Bisht as Company Secretary and Compliance Officer, Effective on February 16, 2023	14.02.23
Concord Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14.02.23
Concord Drugs Limited Announces Resignation of Rakshit Sethiya as Company Secretary and Compliance Officer	11.11.22
Concord Drugs Limited announced that it has received INR 10.364063 million in funding	07.11.22
Concord Drugs Limited Appoints RakshitSethiya as Company Secretary and Compliance Officer	04.11.22
Concord Drugs Limited announced that it expects to receive INR 10.364063 million in funding	07.09.22
Concord Drugs Limited agreed to acquire 100% stake in Proton Remedies Private Limited.	07.09.22
Concord Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13.08.22
Concord Drugs Limited Announces Director Changes	02.06.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Concord Drugs Limited

Aktien

CONCORD6

INE858L01010

CONCORD6

Andere Sprachen

Filter